Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01074021 : Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer
PhasePhase 3
AgesMin: 18 Years Max: 70 Years
Inclusion Criteria:

- Joined the study voluntary and signed informed consent form

- Age 18-70?both genders.

- Nasopharyngeal cancer was confirmed by pathology.

- Nasopharyngeal cancer 2008 Stages: ?/?a.

- Primary lesions can measurable.

- Karnofsky Performance Scale >70.

- Life expectancy of more than 6 months.

- Use of an effective contraceptive method for women when there is a risk of pregnancy
during the study.

- Haemoglobin?100g/L ,WBC ?4×109/L, platelet count?100×109/L

- Hepatic function:ALAT?ASAT< 1.5 x ULN, TBIL< 1.5 x ULN

- Renal function: Creatinine < 1.5 x ULN

Exclusion Criteria:

- Evidence of distant metastasis

- Primary lesions or lymph node have been operated (except of operation for biopsy)

- Previous radiotherapy

- Received other anti EGFR monoclonal antibody treatment

- Previous chemotherapy or immunization therapy

- Other malignant tumor (except of Non-melanoma Skin Cancer or carcinoma in situ of

- Participation in other interventional clinical trials within 1 month

- Peripheral neuropathy is more than I stage

- Pregnant or breast-feeding women and women who refused to take contraceptive method

- History of serious allergic or allergy

- History of Serious lung or heart disease

- Refused or can't signed informed consent form

- Drug abuse or alcohol addiction

- Personality or psychiatric disease, and persons without capacity for civil conduct or
persons with limited capacity for civil conduct
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557